Maria S Kahn

Title: Maria S Kahn: Innovator in Tumor Immunotherapy and Biochemical Processes

Introduction

Maria S Kahn is a prominent inventor based in Seattle, WA, known for her significant contributions to the fields of tumor immunotherapy and biochemical processes. With a total of three patents to her name, Kahn has made strides in developing innovative methods that harness the power of antibodies for therapeutic applications.

Latest Patents

One of Kahn's latest patents focuses on tumor immunotherapy using anti-idiotypic antibodies. This invention relates to methods that utilize these antibodies or their fragments for tumor immunotherapy or immunoprophylaxis. The patent describes the use of monoclonal anti-idiotypic antibodies that recognize an idiotype present on a second antibody, T lymphocyte, or immune suppressor factor directed against a defined tumor antigen. These antibodies can be employed for immunization against tumors, immune anti-tumor activation, or inhibition of suppression. Additionally, they can be used to monitor anti-antibody induction in patients undergoing passive immunization to a tumor antigen. Another significant patent involves the biosynthesis of 2-keto-L-gulonic acid, which details a process for producing this compound from sorbose using recombinant bacteria.

Career Highlights

Throughout her career, Maria S Kahn has worked with notable companies such as Oncogen and Hoffmann-La Roche Inc. Her work has been instrumental in advancing the understanding and treatment of cancer through innovative immunotherapeutic approaches.

Collaborations

Kahn has collaborated with esteemed colleagues, including Ingegerd E Hellstrom and Karl E Hellstrom, contributing to the collective knowledge and advancements in her field.

Conclusion

Maria S Kahn's innovative work in tumor immunotherapy and biochemical processes highlights her role as a leading inventor in the scientific community. Her patents reflect a commitment to improving therapeutic strategies for cancer treatment.